Skip to main content
Fig. 2 | Trials

Fig. 2

From: Effect of intensive care unit-specific virtual reality (ICU-VR) to improve psychological well-being and quality of life in COVID-19 ICU survivors: a study protocol for a multicentre, randomized controlled trial

Fig. 2

Flow diagram of the study. Abbreviations: COVID-19, coronavirus disease 2019; EQ-5D, European Quality of life 5 dimension questionnaire; HADS, Hospital Anxiety and Depression Scale; ICU, intensive care unit; ICU-VR, intensive care unit-specific virtual reality; IES-R, Impact of Event Scale–Revised. Eligible patients will be invited to a post-COVID outpatient clinic and randomized across the early and late ICU-VR group. The early group will receive the ICU-VR intervention during the same visit, while the late group receives ICU-VR during a second outpatient clinic visitation 6 months after hospital discharge. Psychological well-being and quality of life will be assessed 3, 4, 6, 7 and 12 months after hospital discharge using follow-up questionnaires

Back to article page

Trials

ISSN: 1745-6215